DJIA 17,265.99 109.14 0.64%
NASDAQ 4,593.43 31.24 0.68%
S&P 500 2,011.36 9.79 0.49%
market minute promo

Johnson & Johnson (NYSE: JNJ)

107.35 1.16 (1.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $107.35 1.09%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.18
Previous Close $106.19
Daily Range $106.03 - $107.41
52-Week Range $85.50 - $107.41
Market Cap $302.8B
P/E Ratio 19.63
Dividend (Yield) $2.80 (2.6%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,627,842
Average Daily Volume 5,537,576
Current FY EPS $5.92





Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary Rss Feed

Gilead Sciences, inc. Stock's Incoming Game Changer

Gilead's Sovaldi sales could reach $10 billion this year, but sales could head even higher next year if the FDA approves its Sovaldi and ledipasvir combination drug.

Head-To-Head Comparison: Pfizer Vs. Johnson & Johnson On Environmental Metrics

Don't Own A Company If You Wouldn't Display It On Your Wall

3 Hot Ways to Play the Biotechnology Bonanza

New Active ETF for All Risk Environments

Actavis Is The Best Bet In The Drug Sector

Why It's Time for Allergan Shareholders to Take Some Profits

Buy The Dip In Gilead: Why A Decrease In Quarterly Sovaldi Revenue Is Expected

Is There Further Upside In Medivation?

Lawyer grills DePuy executive over safety studies for Pinnacle hips

See More JNJ News...

JNJ's Top Competitors

JNJ $107.35 (1.09%)
Current stock: JNJ
PFE $30.58 (0.76%)
Current stock: PFE
MRK $60.31 (0.72%)
Current stock: MRK
ABT $43.69 (0.71%)
Current stock: ABT